Answers are grounded in this paper and cite their sources.
Cutaneous melanoma is an aggressive skin tumour that accounts for significant mortality. Diagnosis relies on clinical examination and histopathological work-up after surgical removal. Tumour thickness (Breslow depth), determined by the pathologist, is crucial for staging and treatment. Cross-sectional imaging is mainly used to detect metastases, while sonography serves to identify pathologic lymph nodes and guide interventions. However, advances in ultrasound technology provide promising non-invasive evaluation of primary tumours that complements conventional methods. Our aim is to briefly review the currently available ultrasound-based techniques for diagnosing and managing cutaneous melanoma. High-frequency ultrasound can precisely evaluate tumour depth, competing with histopathological measurement. Doppler techniques and elastography, by mapping vascularity and tissue stiffness, provide additional clues to differentiate benign and malignant lesions. Contrast-enhanced ultrasound is not only a valuable tool for characterising the primary tumour and searching for relapse/metastasis, but it is also applied in targeted therapies. New wave ultrasound-based treatment options like sonoporation, sonodynamic therapy, and high-intensity focused ultrasound show promising preclinical results. Adopting artificial intelligence into melanoma care may reduce variability and increase diagnostic and therapeutic accuracy, though clinical validation remains limited.
No takes yet. Share an insight, caveat, or question.
Bencze et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: